Flavonoids, a class of polyphenol secondary metabolites, are presented broadly in plants
and diets. They are believed to have various bioactive effects including anti-viral, anti …

Dietary polyphenols have been widely investigated as antidiabetic agents in cell, animals,
human study, and clinical trial. The number of publication (Indexed by Web of Science) on …

Growing evidence support association between polyphenol intake and reduced risk for
chronic diseases, even if there is a broad debate about the effective amount of polyphenols …

Significant evidence from epidemiological investigations showed that dietary polyphenols
might manage and prevent type 2 diabetes (T2D). This review summarizes human studies …

Polyphenols are a group of secondary plant metabolites widely present in diets and have
antagonistic effects on some chronic metabolic diseases, like type 2 diabetes (T2D) and …

Diabetes mellitus is a group of metabolic disorders of the endocrine system characterised by
hyperglycaemia. Type II diabetes mellitus (T2DM) constitutes the majority of diabetes cases …

Astragalus membranaceus is a medicinal and edible species in China, with a variety of
biological activities. This study evaluated the reuse potential of A. membranaceus waste as …

Diabetes mellitus is a major, global public health problem. α-Glucosidase inhibitors are one
of the most widely used classes of oral antidiabetics. In addition to other pharmaceutical …

Background: Epidemiologic studies demonstrate inverse associations between flavonoid
intake and chronic disease risk. However, lack of comprehensive databases of the flavonoid …

Epidemiological studies have suggested that flavonoids exhibit preventive effects on
degenerative diseases. However, lack of sufficient data on flavonoid intake has limited …